Anna Frank/E+ via Getty Images
Lineage Cell Therapeutics (NYSE:LCTX) is a clinical-stage biotech focusing on several regenerative medicine opportunities that I first wrote about around this time last year. I noted that the company’s pipeline looked very…

Click here to view the original article.